Objective: The purpose of this study was to compare the clinical efficacy and safety of intravenous trospectomycin to that of cefoxitin plus doxycycline in the treatment of women hospitalized with acute pelvic inflammatory disease (PID)

Chatwani, Ashwin

Dandalou, Vani

Harmanli, Ozgur

Nyirjesy, Paul

Crossref

Directory of Open Access Journals

PubMed Central

English

Antinaicrobial formulary management: A case study in a teaching hospital.

BB: In vitro antibacterial activity of trospectonaycin (U-63366F), a novel spectinomycin analog. Antimicrob Agents Chemother 32:216-223,

Calderon JE: In vitro activity of several antinaicrobial agent against genital naycoplasrnas. Clin Ther

et al.: Polynaicrobial etiology of acute PID.

Etiology and outcome of acute PID.

Grayston JT: In vitro drug susceptibility of chlanaydial species strain TWAR. Antimicrob Agents Chenaother 32:257-258,

Jewesson pJ: Comparison of cefoxitin and ceftizoxinae in a hospital therapeutic interchange program.

Leonik KJ: Treatment of gonococcal infections with a single 250 nag intramuscular injection of trospectonaycin sulfate vs. ceftriaxone sodium. Drugs Exp Clin Res 19:41-46,

McDaniel PS: Treatment of serious obstetric and gynecologic infections with cefoxitin.

Microbiological and histopathological findings in acute pelvic inflammatory disease.

MR: Susceptibility of 539 gram positive and gram negative anaerobes to new agents, including RP 59500, biapenena, trospectomycin and piperacillin/tazobactana.

Novak E: Pharnaacokinetics of trospectonaycin sulfate in healthy subjects after single intravenous and intramuscular doses.

Observations concerning the microbial etiology of acute salpingitis.

Standards: Alternative Methods for Antirnicrobial Susceptibility Testing of Anaerobic Bacteria.

Standards: Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically. 2nd edition.

Zurenko GE: The bacterial activity and post-antibiotic effect of trospectomycin.

Trospectomycin in Acute Pelvic Inflammatory Disease: A Preliminary Report

Trospectomycin in acute pelvic inflammatory disease: a preliminary report